Average ApoB Level: Am I Normal?
Apolipoprotein B from a lipid panel: the headcount of artery-clogging particles. Lower is better.
What is a normal ApoB level?+
The population 50th percentile sits around 100 mg/dL, which most labs report as "normal." But normal is not optimal: longevity- and prevention-focused clinicians target under 80 mg/dL, and under 60 in higher-risk patients. ApoB is dose-dependent and cumulative, so lower-for-longer wins.
Is ApoB better than LDL cholesterol?+
When the two disagree (discordance), yes. Each atherogenic particle carries exactly one ApoB, so ApoB is a direct particle count, while LDL-C measures the cholesterol cargo, which varies per particle. Sniderman 2019 found ApoB the superior predictor in discordant cases.
How do I lower my ApoB?+
Reduce saturated fat, raise soluble fiber, lose visceral fat, and add aerobic exercise for modest reductions. For high particle counts, statins (± ezetimibe or PCSK9 inhibitors) are the highest-leverage intervention. The benefit scales with the absolute ApoB reduction achieved.
Does a normal ApoB rule out heart disease risk?+
No. A normal ApoB can still hide a high Lp(a), a separate genetic particle worth measuring once in your life. Inflammation (hs-CRP) and insulin resistance add residual risk on top of particle burden.
What ApoB counts, and why it can beat LDL
Every particle that can carry cholesterol into an artery wall (LDL, VLDL and Lp(a) among them) holds exactly one ApoB molecule, so an ApoB result is a direct count of those particles. LDL cholesterol measures the cholesterol they carry, which varies from particle to particle. Sniderman and Thanassoulis (2019) review the evidence that ApoB measures this risk more accurately than LDL cholesterol or non-HDL cholesterol.
In about 390,000 UK Biobank adults not taking lipid-lowering treatment, ApoB, non-HDL cholesterol and triglycerides each predicted a first heart attack, but when they were assessed together only ApoB stayed linked to risk (Marston 2022). A high ApoB is worth discussing with a clinician alongside the rest of your lipid panel.
- Sniderman AD, Thanassoulis G, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2019;4(12):1287-1295.
- Marston NA, et al. Association of apolipoprotein B-containing lipoproteins and risk of myocardial infarction in individuals with and without atherosclerosis: distinguishing between particle concentration, type, and content. JAMA Cardiol. 2022;7(3):250-256.
See how you compare.
Get the weekly research drop: what the audience actually does, plus the protocols I'm testing on myself. No spam, unsubscribe anytime.
For education, not medical advice. Results are estimates, not a diagnosis. Discuss any abnormal value or health concern with a qualified clinician.